FindMyRecallSubscribe
Class II: temporary or reversible health riskOngoing

Teva Pharmaceuticals Metoprolol Succinate Extended-Release Tablets Recall

Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-6…

Teva Pharmaceuticals USA, Inc · Parsippany, NJ

Risk level
Class II
Reported by FDA
Mar 11, 2026
Recall ID
D-0355-2026
Check your lot numberHow we source this data

Summary

Teva Pharmaceuticals recalled Metoprolol Succinate Extended-Release Tablets starting Jan 29, 2026. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0355-2026 on Mar 11, 2026. Reason: Failed Dissolution Specifications. Status: Ongoing.

Why it was recalled

Failed Dissolution Specifications

Product description

Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles (NDC: 45963-676-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054

Lot numbers, UPCs & expiration codes

Lot#: a) 0486G251, 0487G251, 0488G251, Exp.: 01/2027; b) 0486G252, 0487G253, 0488G252, Exp.: 01/2027.

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0355-2026
Classification
Class II
Status
Ongoing
Recall initiated
Jan 29, 2026
FDA report date
Mar 11, 2026
Quantity
67,043 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
Teva Pharmaceuticals USA, Inc

Original FDA data

Every field from FDA enforcement report D-0355-2026, exactly as published.

Show all FDA fields
City
Parsippany
State
NJ
Status
Ongoing
Country
United States
Event ID
98348
Address
400 Interpace Pkwy Bldg A
Code information
Lot#: a) 0486G251, 0487G251, 0488G251, Exp.: 01/2027; b) 0486G252, 0487G253, 0488G252, Exp.: 01/2027.
Postal code
07054-1120
Report date
Mar 11, 2026
Product type
Drugs
Recall number
D-0355-2026
Classification
Class II
Recalling firm
Teva Pharmaceuticals USA, Inc
Product quantity
67,043 bottles
Reason for recall
Failed Dissolution Specifications
Voluntary / mandated
Voluntary: Firm initiated
Product description
Metoprolol Succinate Extended-Release Tablets, 50 mg, 100 tablets bottles (NDC: 45963-676-11) and 1,000 tablets bottles (NDC: 45963-676-96), Rx Only, Teva Pharmaceuticals, Parsippany, NJ 07054
Distribution pattern
Nationwide
Recall initiation date
Jan 29, 2026
Initial firm notification
Letter
Center classification date
Feb 27, 2026

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0355-2026, published Mar 11, 2026. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls